文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

全身给予同种异体间充质干细胞减轻猪心脏骤停模型复苏后左心室功能障碍

Systemic administration of allogeneic mesenchymal stem cells attenuates post-resuscitation left ventricular dysfunction in a porcine model of cardiac arrest.
PubMed 文献 · Resuscitation · 2025-08-05
一句话结论猪心脏骤停复苏后30分钟经脑室内给予同种异体骨髓间充质干细胞可改善左心室功能、降低肌钙蛋白I并减少升压药需求,提示可能有效。

该研究在33头猪中建立10分钟心脏骤停模型,经机械心肺复苏、除颤及静脉肾上腺素(0.015 mg/kg)后19头实现自主循环恢复(ROSC),盲法随机分为复苏后30分钟脑室内注射生理盐水组(n=9)或同种异体骨髓来源间充质干细胞组(55±2×10^6,n=10)。复苏后按需静脉给予肾上腺素维持平均动脉压≥60 mmHg,监测4小时。与生理盐水组相比,间充质干细胞组左心室功能改善、肌钙蛋白I水平更低,血压和心输出量相似但肾上腺素用量显著更少,血浆活性氧降低,循环IL-6升高趋势减弱。作者认为复苏后早期全身给予间充质干细胞可能改善心脏骤停复苏患者的结局。

要点

  • 猪心脏骤停复苏后30分钟脑室内给予同种异体骨髓间充质干细胞(55±2×10^6),4小时内左心室功能优于生理盐水组。
  • 间充质干细胞组肌钙蛋白I水平低于生理盐水组,提示心肌损伤减轻。
  • 两组复苏后血压和心输出量相似,但生理盐水组所需肾上腺素显著更多。
  • 间充质干细胞组血浆活性氧降低,循环IL-6复苏后升高呈减弱趋势。
  • 作者认为复苏后早期全身给予间充质干细胞可能是改善心脏骤停复苏患者结局的有效策略。

适用人群与场景

  • 猪心脏骤停模型:10分钟心脏骤停后经机械心肺复苏、除颤及静脉肾上腺素(0.015 mg/kg)实现自主循环恢复(ROSC)的动物(n=19)。
  • 复苏后30分钟盲法随机分组,随访至ROSC后4小时。

处置流程与药物剂量

  • 心脏骤停10分钟后行机械心肺复苏、除颤,并静脉给予肾上腺素0.015 mg/kg。
  • ROSC后30分钟脑室内给予同种异体骨髓来源间充质干细胞55±2×10^6(n=10)或生理盐水(n=9)。
  • 复苏后按需静脉给予肾上腺素维持平均动脉压≥60 mmHg。
  • ROSC后4小时内行超声心动图、血流动力学分析及系列采血,随后取心脏和脑行炎症与损伤死后分析。

研究设计与关键结果

  • 研究类型:猪心脏骤停模型研究;33头猪接受10分钟心脏骤停,19头实现ROSC并随机分组(间充质干细胞组n=10,生理盐水组n=9)。
  • 与生理盐水组相比,间充质干细胞组复苏后左心室功能改善、肌钙蛋白I水平更低。
  • 两组复苏后血压和心输出量相似,但生理盐水组所需肾上腺素显著更多。
  • 间充质干细胞组血浆活性氧降低,循环IL-6复苏后升高呈减弱趋势。

证据类型、等级与局限

  • 证据类型:动物(猪)实验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,复苏后早期全身给予同种异体间充质干细胞可能改善心脏骤停复苏患者的结局。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Based on evidence that a systemic inflammatory response exacerbates multi-organ injury after resuscitation from cardiac arrest (CA), we tested the efficacy of allogeneic mesenchymal stem cell (MSC) administration early after return of spontaneous circulation (ROSC) in a porcine model of CA.

METHODS: Swine (n = 33) were subjected to 10-min CA followed by mechanical CPR with defibrillation and intravenous epinephrine (EPI; 0.015 mg/kg). Animals that achieved ROSC (n = 19) were blindly randomized to intraventricular saline (n = 9) or allogeneic bone marrow-derived MSCs (55 ± 2 × 106; n = 10) 30-min post-ROSC. Intravenous EPI was given during the post-ROSC period as needed to maintain MAP ≥ 60 mmHg. Echocardiography, hemodynamic analysis, and serial blood sampling were performed for 4-hours post-ROSC, at which time the heart and brain were collected for post-mortem analysis of inflammation and injury.

RESULTS: Compared with saline-treated controls, MSC-treated animals exhibited improved post-ROSC LV function and lower cTnI levels, indicative of reduced myocardial injury. By design, both groups had a similar post-ROSC blood pressure and cardiac output, but the saline group required significantly more EPI. Allogeneic MSCs also decreased plasma reactive oxygen species and tended to attenuate the post-ROSC rise in circulating IL-6.

CONCLUSIONS: Early post-ROSC delivery of allogeneic MSCs attenuates LV dysfunction and reduces the need for pharmacologic hemodynamic support after CA in swine, suggesting that systemic MSC administration may be an effective strategy to improve patient outcomes after resuscitation from CA.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Nsumbu D, Rolland TJ, Tajlil A, et al. Systemic administration of allogeneic mesenchymal stem cells attenuates post-resuscitation left ventricular dysfunction in a porcine model of cardiac arrest. Resuscitation. 2025. PMID: 40754261. doi:10.1016/j.resuscitation.2025.110744

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。